Anticoagulation Therapy After Biologic Aortic Valve Replacement

Objectives: Thromboembolism prophylaxis after biologic aortic valve replacement (BAVR) is recommended for 3 months postoperatively. We examined the continuation of oral anticoagulation (OAC) treatment and its effect on the long-term prognosis after BAVR. Methods: We used nation-wide register data fr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Cardiovasc Med
Main Authors: Myllykangas, Monna E., Kiviniemi, Tuomas O., Gunn, Jarmo M., Salomaa, Veikko V., Pietilä, Arto, Niiranen, Teemu J., Aittokallio, Jenni
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Cardiovascular Medicine
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256261/
https://ncbi.nlm.nih.gov/pubmed/34235192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.698784
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares